Pathologic scoring of PTEN immunohistochemistry in endometrial carcinoma is highly reproducible (Q34574472)

3 August 2017

Pathologic scoring of PTEN immunohistochemistry in endometrial carcinoma is highly reproducible (English)

1 reference

3 August 2017

1 reference

1 reference

endometrial carcinoma

1 reference

Karuna Garg

1

1 reference

3 August 2017

Russell R Broaddus

2

1 reference

3 August 2017

Robert A Soslow

3

1 reference

3 August 2017

Diana L Urbauer

4

1 reference

3 August 2017

Douglas A Levine

5

1 reference

3 August 2017

Bojana Djordjevic

6

1 reference

3 August 2017

1 January 2012

1 reference

International Journal of Gynecological Pathology

3 August 2017

1 reference

3 August 2017

31

1 reference

3 August 2017

1

1 reference

3 August 2017

48-56

1 reference

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

A robust immunohistochemical assay for detecting PTEN expression in human tumors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

PI(3)king apart PTEN's role in cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

Phosphatidylinositol 3-kinase inhibitors: promising drug candidates for cancer therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

Molecular identification of latent precancers in histologically normal endometrium.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

PTEN/MMAC1 mutations in endometrial cancers.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

Two pathogenetic types of endometrial carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

The Measurement of Observer Agreement for Categorical Data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immuno

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

Combined PTEN and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4244710

PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22123723

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22123723

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22123723

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/PGP.0B013E3182230D00

1 reference

3 August 2017

1 reference

3 August 2017

1 reference